ArticleMacromolecular bioscience2025
Novel Antioxidant and Antibacterial Injectable Hydrogels Incorporating Clove Oil-Loaded Mesoporous Bioactive Glass Nanoparticles: A Promising Strategy for Enhanced Bone Regeneration.
Article in Macromolecular bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alginate (Alg)-gelatin (Gel)-xanthan gum (Xan) injectable hydrogels incorporating mesoporous bioactive glass nanoparticles (MBGNs) loaded with different concentrations of clove oil (MBGNs+CLV) were developed for bone regeneration applications. The hydrogels exhibited an interconnected network of pores, with their dimensions fulfilling the requirements for bone tissue engineering. MBGNs+CLV were successfully embedded within the Alg-Gel-Xan matrix. The presence of CLV in the hydrogel was proven by the total phenolic content (TPC), which was further correlated with the enhanced antioxidant activity, which increased with higher CLV concentrations. Simultaneously, the addition of MBGNs+CLV led to an increase of the hydrogel's Young's modulus, while maintaining its injectability and adhesion properties. Based on the CLV release profile, a burst release was followed by a sustained and controlled release, which was independent of the loaded CLV concentration. The drug release profiles were further correlated with the degradation study, revealing the possible mechanism of drug release. The MBGNs+CLV-based hydrogel possessed strong antibacterial properties and promoted MC3T3-E1 pre-osteoblast cell viability without altering cell morphology. In conclusion, our study highlights the potential of Alg-Gel-Xan containing MBGNs+CLV as an antioxidant injectable hydrogel with controlled and sustained CLV delivery, offering a promising strategy for stimulating bone regeneration and addressing bone infection and oxidative stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.